Maduck Sean 4
4 · CORCEPT THERAPEUTICS INC · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
Corcept (CORT) President Sean Maduck Gifts 54,570 Shares
What Happened
- Sean Maduck, President of Corcept Endocrinology, reported intra-personal transfers on Jan 8, 2026 that are reported as gifts. He disposed of a total of 54,570 shares (20,570 and 34,000) at $0.00 per share (total reported value $0). Matching "other acquisition or disposition" (code J) entries for the same amounts were also reported, reflecting transfers into accounts/entities for which he serves in fiduciary or managerial roles.
- These were not sales for cash — they were gifts/transfers and therefore do not directly indicate a buy or sell investment decision.
Key Details
- Transaction date(s): January 8, 2026; Price: $0.00 per share; Total shares transferred: 54,570.
- Form filed: February 13, 2026 (period of report: 2026-01-08). The filing was submitted roughly 36 days after the transaction date and appears late relative to the typical 2-business-day Form 4 filing requirement.
- Shares owned after transaction: not specified in the excerpt provided — see the full Form 4 for total beneficial ownership.
- Relevant footnotes: transfers involve trusts and entities where Maduck is trustee, co-trustee, member or manager (F1–F6). F4 lists 1,587 unvested restricted shares (266 + 888 + 228 + 205) that vest one year after each grant date; F6 notes Duckhill Capital, LLC holdings for which he disclaims beneficial ownership except to the extent of pecuniary interest.
- Remark on role: Reporting person listed as President, Corcept Endocrinology. Power of attorney under which the form was signed is on file with the SEC.
Context
- Gift transactions (code G) are transfers of shares without cash consideration and generally do not signal the insider’s view on the company’s stock. Code J entries (other acquisition/disposition) are commonly used to report transfers between accounts or into trusts/LLCs rather than market trades.
- Because the transfers involve trusts and entities that Maduck manages or serves as trustee, these filings largely reflect reallocation of ownership/control, not open-market selling.
Insider Transaction Report
Form 4
Maduck Sean
See Remarks
Transactions
- Gift
Common Stock
[F1]2026-01-08−20,570→ 39,147 total(indirect: See Footnote) - Other
Common Stock
[F2]2026-01-08+20,570→ 20,570 total(indirect: See Footnote) - Gift
Common Stock
[F1]2026-01-08−34,000→ 5,147 total(indirect: See Footnote) - Other
Common Stock
[F3]2026-01-08+34,000→ 34,000 total(indirect: See Footnote)
Holdings
- 8,179
Common Stock
[F4] - 40,000(indirect: See Footnote)
Common Stock
[F5] - 10,000(indirect: See Footnote)
Common Stock
[F6]
Footnotes (6)
- [F1]Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee.
- [F2]Represents the shares held by MMM 2025, LLC of which the Reporting Person is a member and manager.
- [F3]Represents the shares held by SNM 2026 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.
- [F4]Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 205 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- [F5]Represents the shares held by SNM 2025 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.
- [F6]Represents the shares held by Duckhill Capital, LLC of which the Reporting Person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Sean Maduck|2026-02-13